BETA: Please send your feedback!
Wave Life Sciences
WVE:NAS
Biotechnology
$740.64mm
SMALL cap
$21.61
(1.03%)
-0.45%
since start of 2019
-4.20
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2012
Wave Life Sciences Ltd. operates as a preclinical biopharmaceutical company, which engages in the development and provision of nucleic acid therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.
website
Headquarters
Executives
| Name | Title | Gender |
| Gregory L. Verdine, PhD | Chairman | Male |
| Paul B. Bolno, MD, MBA | President, Chief Executive Officer & Director | Male |
| Keith Regnante, MBA | Chief Financial Officer | Male |
| Linda K. Rockett | General Counsel | Female |
| Takeshi Wada | Founder | Male |
| Peter Lasky | Chief Human Resources Officer & Senior VP | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 1
Wave Life Sciences - Competitors and Related Companies
How Wave Life Sciences stacks up to its peers in the Biotechnology industry or with competing business segments.
Wave Life Sciences
WVE:NAS
Biotechnology
$740.64mm
SMALL cap
$21.61
(1.03%)
-0.45%
since start of 2019
-4.20
E ON
EOAN-DE:ETR
Electric Utilities
—
LARGE cap
(—)
—
since start of 2019
—
Exelon
EXC:NYS
Electric Utilities
$43.45bn
LARGE cap
$44.72
(0.06%)
0.01%
since start of 2019
19.06
NextEra Energy
NEE:NYS
Electric Utilities
$113.78bn
MEGA cap
$232.80
(0.32%)
0.37%
since start of 2019
33.21